ADARx Pharmaceuticals, Inc. Common Stock (ADRX) stock: key figures, P/E, revenue and dividend
Health Care · United States
ADARx Pharmaceuticals, Inc. Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 3.45 m USD |
| Operating income | -58.23 m USD | -88.37 m USD |
| EBIT | -58.23 m USD | -88.37 m USD |
| Net income | -46.36 m USD | -73.09 m USD |
| Diluted EPS – continuing operations | -0.45 USD | -0.72 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ADARx Pharmaceuticals, Inc. Common Stock
ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases. The company offers hepatic-targeted programs, including Agazisiran, a complement factor B (CFB) program that represents a pipeline-in-a-product opportunity, where a single therapeutic candidate has the potential to address multiple indications; Onvuzosiran, a clinical program for the prevention of HAE attacks; and ADX-626, a Factor XI (FXI) program for secondary stroke prevention with additional clinical potential for stroke prevention in atrial fibrillation. It also offers extrahepatic-targeted programs, such as ADX-077, an adipose-targeted obesity program designed to reduce body weight and fat while preserving lean mass; and ADX-199, a neuron-targeted program designed to selectively silence and degrade amyloid-ß precursor protein (APP) mRNA in neurons, which is genetically linked to Alzheimer's disease. The company was incorporated in 2019 and is based in San Diego, California.
More stocks
- Perella Weinberg Partners (PWP)
- NCR Voyix Corp (VYX)
- Beijing Shunxin Agriculture Co Ltd (000860.SZ)
- 4iG Nyrt (4IG.BD)
- LuxNet (4979.TWO)
- FAP Agri Tbk PT (FAPA.JK)
- TRIMAS CORP (TRS)
- Shanxi Lanhua Sci-Tech Venture Co Ltd (600123.SS)
- Topoint Technology Co Ltd (8021.TW)
- Shanghai OPM Biosciences Co. Ltd. A (688293.SS)
- NEXTNAV INC. (NN)
- 3R Petroleum Oleo E Gas SA Ordinary Shares (BRAV3.SA)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.